Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes

BACKGROUND: Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is unknown. Metabolomics may help identify novel biomarkers potentially involved in development...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zhe, Klaric, Lucija, Krasauskaite, Justina, McLachlan, Stela, Strachan, Mark W. J., Wilson, James F., Price, Jackie F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047374/
https://www.ncbi.nlm.nih.gov/pubmed/35477395
http://dx.doi.org/10.1186/s12933-022-01493-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047374/
https://www.ncbi.nlm.nih.gov/pubmed/35477395
http://dx.doi.org/10.1186/s12933-022-01493-w

Ejemplares similares